Akamai estimates, target raised at Credit Suisse
Shares of AKAM now seen reaching $22.50, according to Credit Suisse. Estimates also increased, to match the company's new guidance. Neutral rating.
-----
American Capital estimates cut at UBS
AGNC estimates lowered through 2012, UBS said. Higher prepayment assumptions and a mix shift to lower coupon securities. Maintain $29 price target and Buy rating.
-----
Avery Dennison numbers lowered at Credit Suisse
AVY estimates were cut through 2012, Credit Suisse said. Company reduced its guidance. Neutral rating and new $34 price target.
-----
Bank of America downgraded at Morgan Stanley
BAC was downgraded from Overweight to Equal-weight, Morgan Stanley said. $10 price target. Earnings will continue to be pressured from macro growth concerns. $10 price target.
-----
Bemis estimates, target cut at Jefferies
BMS estimates were reduced through 2012, Jefferies said. Volumes are likely to remain sluggish. Hold rating and new $29 price target.
-----
Boeing estimates adjusted at UBS
BA 2012 EPS estimates lowered mainly for higher pension expenses. Maintain $66 price target and Neutral rating.
-----
Brinker downgraded at Sterne Agee
EAT was downgraded from Neutral to Underperform, Sterne Agee said. Valuation call, based on a $20 price target.
-----
Brinker estimates, target increased at UBS
Shares of EAT now seen reaching $27, according to UBS. Estimates also increased as company suggests October SSS are solid. Buy rating.
-----
CA estimates, target cut at Credit Suisse
Shares of CA now seen reaching $22, according to Credit Suisse. New product sales are declining. Neutral rating.
-----
CA downgraded at Evercore
CA was downgraded to Equal-weight, Evercore Partners said. Valuation call, based on a $24 price target.
-----
Charles Schwab numbers reduced at Credit Suisse
Shares of SCHW now seen reaching $16, according to Credit Suisse. Estimates also cut, as the company faces macro headwinds. Outperform rating.
-----
Cisco upgraded at UBS
CSCO was upgraded from Neutral to Buy, UBS said. $19.75 price target. US networking demand remains solid, street estimates reasonable.
-----
Cognizant estimates, target increased at Morgan Stanley
CTSH estimates were raised through 2013, Morgan Stanley said. Company has solid operating momentum. Equal-weight rating and new $78 price target.
-----
ConocoPhillips numbers raised at UBS
Shares of COP now seen reaching $68, according to UBS. Estimates also increased on better than expected 3Q results. Neutral rating.
-----
Dr. Pepper Snapple downgraded at Morgan Stanley
DPS was downgraded from Equal-weight to Underweight, Morgan Stanley said. $36 price target. Profit trends remain weak.
-----
Dr. Pepper Snapple estimates lowered at UBS
DPS estimates lowered through 2012, UBS said. COGS inflation, higher spending to weigh on profitability near term. Maintain $40 price target and Neutral rating.
-----
FMC Technologies numbers lowered at Credit Suisse
FTI estimates were cut through 2012, Credit Suisse said. Company is struggling to manage its growth. Neutral rating and new $45 price target.
-----
Ford estimates, target reduced at Credit Suisse
Shares of F now seen reaching $14, according to Credit Suisse. Estimates also cut, as the company is seeing lower sales in Europe. Neutral rating.
-----
Ford estimates cut at UBS
F estimates lowered through 2011, UBS said. Reflects lower guided operating margins. Maintain $15 price target and Buy rating.
-----
Hess estimates, target cut at UBS
Shares of HES now seen reaching $79, according to UBS. Estimates also lowered on higher E&P costs. Maintain Buy rating.
-----
Hologic downgraded at Ticonderoga
HOLX was downgraded from Buy to Neutral, Ticonderoga said. New product launch is moving slower than expected.
-----
Hospira upgraded at BofA/Merrill
HSP was upgrade from Neutral to Buy, Bank of America/Merrill Lynch said. Valuation call, based on a $48 price target.
-----
Itron estimates, target lowered at Jefferies
ITRI estimates were cut through 2012, Jefferies said. Company is facing higher warranty costs. Buy rating and new $46 price target.
-----
Jarden estimates, target upped at Oppenheimer
JAH estimates were boosted through 2012, Oppenheimer said. Company is posting higher organic sales growth. Outperform rating and new $44 price target.
-----
Mastercard estimates, target raised at Morgan Stanley
Shares of MA now seen reaching $375, according to Morgan Stanley. Estimates also increased, given better industry trends. Overweight rating.
-----
MeadWestvaco downgraded at BMO
MWV was downgraded from Outperform to Underperform, BMO Capital said. Industry prices are falling. $25 price target.
-----
Norfolk Southern numbers raised at Credit Suisse
Shares of NSC now seen reaching $90, according to Credit Suisse. Estimates also increased, as the company is realizing higher margins. Outperform rating.
-----
Novellus estimates, target boosted at Credit Suisse
Shares of NVLS now seen reaching $40, according to Credit Suisse. Estimates also upped, to match the company's new guidance. Neutral rating.
-----
O'Reilly Automotive numbers boosted at Credit Suisse
Shares of ORLY now seen reaching $76, according to Credit Suisse. Estimates also upped, as the company continues to deliver solid growth. Outperform rating.
-----
Owens Corning upgraded at Stifel
OC was upgraded from Hold to Buy, Stifel Nicolaus said. Valuation call, based on a $36 price target.
-----
Panera Bread downgraded at Sterne Agee
PNRA was downgraded from Buy to Neutral, Sterne Agee said. Valuation call, despite rising estimates.
-----
Praxair downgraded at BofA/Merrill
PX was downgraded from Buy to Underperform, Bank of America/Merrill Lynch said. Valuation call, based on a $110 price target.
-----
Range Resources numbers upped at Credit Suisse
RRC estimates were boosted through 2013, Credit Suisse said. Company boosted its production guidance. Outperform rating and new $81 price target.
-----
Sealed Air numbers reduced at Jefferies
Shares of SEE now seen reaching $24, according to Jefferies. Estimates also cut, as the company has limited sales visibility. Buy rating.
-----
Sprint Nextel estimates lowered at UBS
S estimates lowered through 2012, UBS said. 2012 wireless margins will come down to 10.5% of sales. Maintain $2.75 price target and Neutral rating.
-----
Thermo Fisher numbers cut at Oppenheimer
TMO estimates were reduced through 2012, Oppenheimer said. Company is seeing lower end-market demand. Outperform rating and new $59 price target.
-----
Thermo Fisher numbers cut at UBS
Shares of TMO now seen reaching $60, according to UBS. Estimates also lowered on weakness in academic spending. Buy rating.
-----
Vale estimates, target cut at Morgan Stanley
VALE estimates were reduced through 2012, Morgan Stanley said. Company is leveraged to lower iron ore prices. Equal-weight rating and new $29 price target.
-----
Visa downgraded at FBR
Rating on V was lowered to Market Perform from Outperform, FBR Capital Markets said. $96 price target. Company is increasing incentives and domestic debit volumes are falling.
-----
Wellpoint estimates, target increased at Oppenheimer
WLP estimates were raised through 2012, Oppenheimer said. Company is realizing higher enrollment growth. Outperform rating.
-----
WellPoint estimates raised at UBS
WLP estimates increased through 2011, UBS said. Management reiterated long term EPS growth target of 10%. Maintain $79price target and Buy rating.
